ThiazolidinedionesYKI-JÄRVINEN, Hannele.The New England journal of medicine. 2004, Vol 351, Num 11, pp 1106-1118, issn 0028-4793, 13 p.Article

Sequence variation in PPARG may underlie differential response to troglitazoneWOLFORD, Johanna K; YEATTS, Kimberly A; DHANJAL, Sharanjeet K et al.Diabetes (New York, NY). 2005, Vol 54, Num 11, pp 3319-3325, issn 0012-1797, 7 p.Article

Troglitazone : the lesson that nobody learned?GALE, Edwin A. M.Diabetologia (Berlin). 2006, Vol 49, Num 1, pp 1-6, issn 0012-186X, 6 p.Article

Visfatin is an adipokine, but it is not regulated by thiazolidinedionesHAMMARSTEDT, Ann; PIHLAJAMÄKI, Jussi; SOPASAKIS, Victoria Rotter et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 3, pp 1181-1184, issn 0021-972X, 4 p.Article

Thiazolidinediones and fluid retentionKIRYLUK, K; ISOM, R.Kidney international. 2007, Vol 72, Num 6, pp 762-768, issn 0085-2538, 7 p.Article

Ineffectiveness of rosiglitazone therapy in nelson's syndromeMUNIR, A; SONG, F; INCE, P et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 5, pp 1758-1763, issn 0021-972X, 6 p.Article

Ontology-based knowledge management of troglitazone-induced hepatotoxicityHUG, Hubert; DANNECKER, Robert; SCHINDLER, Richard et al.Drug discovery today. 2004, Vol 9, Num 22, pp 948-954, issn 1359-6446, 7 p.Article

Effects of troglitazone in young first-degree Relatives of patients with type 2 diabetesLEVIN, Klaus; HOTHER-NIELSEN, Ole; HENRIKSEN, Jan Erik et al.Diabetes care. 2004, Vol 27, Num 1, pp 148-154, issn 0149-5992, 7 p.Article

Progress with thiazolidinediones in the management of type 2 diabetes mellitusMERIDEN, Terry.Clinical therapeutics. 2004, Vol 26, Num 2, pp 177-190, issn 0149-2918, 14 p.Article

Thiazolidinediones: metabolic actions in vitroFÜRNSINN, C; WALDHÄUSL, W.Diabetologia (Berlin). 2002, Vol 45, Num 9, pp 1211-1223, issn 0012-186X, 13 p.Article

Clinical implications of the DREAM study. CommentaryDAVIDSON, Mayer B.Diabetes care. 2007, Vol 30, Num 2, pp 418-420, issn 0149-5992, 3 p.Article

Treatment of necrobiosis lipoidica with pioglitazoneBOYD, Alan S.Journal of the American Academy of Dermatology. 2007, Vol 57, Num 5, issn 0190-9622, S120-S121, SUPArticle

Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro : Potential for interactions with CYP2C8 inhibitorsJAAKKOLA, Tiina; LAITILA, Jouko; NEUVONEN, Pertti J et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 99, Num 1, pp 44-51, issn 1742-7835, 8 p.Article

Thiazolidinedione use and bone loss in older diabetic adultsSCHWARTZ, Ann V; SELLMEYER, Deborah E; SEOK WON PARK et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 9, pp 3349-3354, issn 0021-972X, 6 p.Article

The pharmacokinetics of pioglitazone in Thai healthy subjectsWITTAYALERTPANYA, Supeecha; CHOMPOOTAWEEP, Sumana; THAWORN, Nongnuch et al.Chot Mai Het Thang Phaet. 2006, Vol 89, Num 12, pp 2116-2122, issn 0125-2208, 7 p.Article

How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?FREEMANTLE, Nick.BMJ. British medical journal (International ed.). 2005, Vol 331, Num 7520, pp 836-838, issn 0959-8146, 3 p.Article

Placental transfer of rosiglitazone in the first trimester of human pregnancyCHAN, Louis Yik-Si; YEUNG, John Hok-Keung; TZE KIN LAU et al.Fertility and sterility. 2005, Vol 83, Num 4, pp 955-958, issn 0015-0282, 4 p.Article

The treatment of non-alcoholic steatohepatitis with thiazolidinedionesREYNAERT, H; GEERTS, A; HENRION, I et al.Alimentary pharmacology & therapeutics. 2005, Vol 22, Num 10, pp 897-905, issn 0269-2813, 9 p.Article

Thiazolidinediones inhibit proliferation of microvascular and macrovascular cells by a PPARγ-independent mechanismARTWOHL, M; FÜRNSINN, C; WALDHÄUSL, W et al.Diabetologia (Berlin). 2005, Vol 48, Num 3, pp 586-594, issn 0012-186X, 9 p.Article

Direct thiazolidinedione action in the human ovary : Insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 productionSETO-YOUNG, Donna; PALIOU, Maria; SCHLOSSER, Jonathan et al.The Journal of clinical endocrinology and metabolism. 2005, Vol 90, Num 11, pp 6099-6105, issn 0021-972X, 7 p.Article

Actualités sur les glitazones = Actualities on thiazolidinedionesSAUVANET, Jean-Pierre.Annales d'endocrinologie. 2005, Vol 66, Num 2, issn 0003-4266, 101 p., CAH2Conference Proceedings

Synthèse et étude structurale de nouvelles 4-thioxothiazolidin-2-ones substituées = New substituted 4-thioxothiazolidin-2-one derivatives: synthesis and structural studyCHANTEGREL, J; ALBUQUERQUE, J. C; GUARDA, V. L et al.Annales pharmaceutiques françaises. 2002, Vol 60, Num 6, pp 403-409, issn 0003-4509, 7 p.Article

Rosiglitazone decreases 11 β-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissueMAI, Knut; ANDRES, Janin; BOBBERT, Thomas et al.Clinical endocrinology (Oxford. Print). 2007, Vol 67, Num 3, pp 419-425, issn 0300-0664, 7 p.Article

Meta-analysis of the effect of thiazolidinediones on serum C-reactive protein levelsQAYYUM, Rehan; ADOMAITYTE, Jurga.The American journal of cardiology. 2006, Vol 97, Num 5, pp 655-658, issn 0002-9149, 4 p.Article

Rosiglitazone therapy of posttransplant diabetes mellitusVILLANUEVA, Griselda; BALDWIN, David.Transplantation. 2005, Vol 80, Num 10, pp 1402-1405, issn 0041-1337, 4 p.Article